Clinical Trial Update: Prevention of Atrial Fibrillation Following Valvular Replacement With Cardiopulmonary Bypass: a Prospective, Randomized Clinical Study Comparing Oral Caffeine With Placebo [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing oral caffeine to placebo to prevent atrial fibrillation after valvular replacement with cardiopulmonary bypass has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Caffeine (caffeine)

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED